Le Lézard
Classified in: Health, Science and technology
Subject: Award

TScan Founders Lea Hachigian and Tomasz Kula Named in Forbes 2020 "30 Under 30" List


TScan Therapeutics recognizes its co-founders, Lea Hachigian Ph.D. and Tomasz Kula Ph.D., who were honored as healthcare pioneers in the Forbes 30 Under 30 list Class of 2020. The Forbes 30 Under 30 lists are awarded annually and are determined by a group of recognized healthcare leaders.

"The entire TScan team congratulates Lea and Tomasz for this well-deserved honor. TScan's core T-cell receptor (TCR) discovery technology was developed by Tomasz in the laboratory of Lasker Award-winner Dr Stephen Elledge at Harvard Medical School. Tomasz and Lea then founded TScan to refine the technology and Lea led the charge in formulating the company's strategy to generate novel immunotherapies based on the technology.

"Tomasz and Lea's efforts are the foundation for TScan's great potential to truly unlock the power of immunotherapy. TScan's unique high-throughput, whole-genome and unbiased technology to simultaneously discover the targets of tumor-reactive TCRs and accurately determine any potential off-target effects helps resolve the two greatest obstacles to advancing novel T cell-based immuno-oncology therapies," continued David P. Southwell, President and Chief Executive Officer.

The entire 2020 Forbes 30 Under 30 Healthcare list can be found here.

About TScan Therapeutics

TScan designs therapies that reprogram a patient's own T cells to recognize and fight their cancer using naturally-occurring TCRs that find and destroy shared cancer targets. The TScan technology process allows TCRs to be scanned against target antigens in a genome-wide, high-throughput, and unbiased fashion. TScan is developing a portfolio of TCR therapies for patients suffering from both liquid and solid tumors, and has already discovered, through this process, novel antigens from TCRs, novel TCRs from known antigens, and previously uncharacterized off-targets of known TCRs.

For more information, please visit www.tscan.com.


These press releases may also interest you

8 aoû 2020
LES Spine Innovations and Sagitechnology are proud to announce the launch of the new A-CIFT SoloFuse Hyperlordotic Cervical Standalone Interbody System, the first ever HA impregnated standalone cervical cage for greater sagittal correction. The...

8 aoû 2020
Symbria Inc. is pleased to announce that it is being featured in a nationally distributed television program, Behind the Scenes with Laurence Fishburne. Behind The Scenes is known for providing factual, unbiased information and specializes in mining...

8 aoû 2020
In lieu of an in-person update to the media, Dr. Theresa Tam, Canada's Chief Public Health Officer, issued the following statement today: "There have been 118,985 cases of COVID-19 in Canada, including 8,970 deaths. 87% of people have now recovered....

8 aoû 2020
The latest data of the evolution of COVID-19 in Québec reveal 126 new cases, bringing the total number of people infected to 60,367. During this same period, 4 new deaths were recorded, to which need to be added 1 death that occurred before July 31,...

8 aoû 2020
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, today...

8 aoû 2020
Bristol Myers Squibb today announced that Opdivo® (nivolumab) plus Yervoy® (ipilimumab) demonstrated a significant improvement in overall survival (OS) in patients with previously untreated, unresectable malignant pleural mesothelioma (MPM) in the...



News published on 9 december 2019 at 07:35 and distributed by: